Clinical Utility of the Pretreatment Glasgow Prognostic Score in Patients with Advanced Inoperable Non-small Cell Lung Cancer-Reference-Cited by-同舟云学术

Clinical Utility of the Pretreatment Glasgow Prognostic Score in Patients with Advanced Inoperable Non-small Cell Lung Cancer

Published:2012-04 Issue:4 Volume:7 Page:655-662
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Leung Elaine Y.L.,Scott Hazel R.,McMillan Donald C.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference30 articles.

1. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer;Scott;Br J Cancer,2002

2. Baseline nutritional evaluation in metastatic lung cancer patients: Mini Nutritional Assessment versus weight loss history;Gioulbasanis;Ann Oncol,2011

3. Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative/supportive care;MacDonald;J Support Oncol,2007

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integration of on-treatment modified Glasgow prognostic score (mGPS) to improve imaging-based prediction of outcomes in patients with non-small cell lung cancer on immune checkpoint inhibition;Lung Cancer;2024-03

2. Palliative radiotherapy for gynecologic malignancies;Palliative Radiation Oncology;2024

3. Prognostic Value of the Glasgow Prognostic Score in Non-Small Cell Lung Cancer Patients Receiving Immunotherapy: A Meta-Analysis;Nutrition and Cancer;2023-12-23

4. Predicting outcomes of Lung Cancer using the modified glasgow prognostic score: A systematic review and meta-analysis;Pakistan Journal of Medical Sciences;2023-12-18

5. Prognostic Potential of the Prognostic Nutritional Index in Non-Small Cell Lung Cancer Patients Receiving Pembrolizumab Combination Therapy with Carboplatin and Paclitaxel/Nab-Paclitaxel;Oncology;2023-08-18